| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,275 |
7,610 |
$488K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,845 |
4,499 |
$308K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,292 |
1,289 |
$141K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,288 |
1,283 |
$126K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,004 |
984 |
$102K |
| 99051 |
|
3,788 |
3,664 |
$98K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
842 |
827 |
$83K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,752 |
2,679 |
$38K |
| 87428 |
|
1,194 |
1,160 |
$37K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
420 |
410 |
$17K |
| 92551 |
|
3,002 |
2,976 |
$16K |
| 99173 |
|
3,001 |
2,972 |
$16K |
| 99215 |
Prolong outpt/office vis |
109 |
103 |
$10K |
| G0009 |
Administration of pneumococcal vaccine |
280 |
280 |
$3K |
| G0008 |
Administration of influenza virus vaccine |
235 |
235 |
$3K |
| 96161 |
|
501 |
497 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
99 |
98 |
$2K |
| 90749 |
|
109 |
108 |
$1K |
| 99072 |
|
136 |
131 |
$1K |
| 96127 |
|
1,180 |
1,159 |
$1K |
| 99188 |
|
46 |
46 |
$962.28 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
58 |
58 |
$769.17 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
30 |
29 |
$766.65 |
| 96160 |
|
1,355 |
1,335 |
$645.05 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
648 |
638 |
$538.31 |
| 90698 |
|
305 |
273 |
$519.75 |
| 90670 |
|
365 |
331 |
$519.75 |
| 90680 |
|
120 |
114 |
$346.50 |
| 90633 |
|
163 |
163 |
$265.65 |
| 90686 |
|
144 |
144 |
$231.00 |
| 90688 |
|
134 |
111 |
$231.00 |
| 90651 |
|
142 |
133 |
$196.35 |
| 90744 |
|
41 |
41 |
$161.70 |
| 81002 |
|
39 |
39 |
$156.46 |
| 90619 |
|
131 |
131 |
$103.95 |
| 90734 |
|
17 |
12 |
$80.85 |
| 90677 |
|
68 |
60 |
$0.00 |
| 90697 |
|
14 |
14 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
272 |
271 |
$0.00 |
| 90620 |
|
27 |
27 |
$0.00 |
| 90696 |
|
13 |
13 |
$0.00 |
| 90716 |
|
12 |
12 |
$0.00 |
| G9920 |
Screening performed and negative |
450 |
450 |
$0.00 |
| 90710 |
|
26 |
26 |
$0.00 |
| 83655 |
|
95 |
95 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
13 |
13 |
$0.00 |
| 80061 |
Lipid panel |
96 |
96 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
25 |
25 |
$0.00 |
| 90715 |
|
52 |
52 |
$0.00 |
| 90661 |
|
64 |
64 |
$0.00 |